These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Hsp90 inhibitor geldanamycin increases the sensitivity of resistant ovarian adenocarcinoma cell line A2780cis to cisplatin. Solár P; Horváth V; Kleban J; Koval' J; Solárová Z; Kozubík A; Fedorocko P Neoplasma; 2007; 54(2):127-30. PubMed ID: 17319785 [TBL] [Abstract][Full Text] [Related]
46. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. Xu W; Mimnaugh E; Rosser MF; Nicchitta C; Marcu M; Yarden Y; Neckers L J Biol Chem; 2001 Feb; 276(5):3702-8. PubMed ID: 11071886 [TBL] [Abstract][Full Text] [Related]
47. Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Holmes JL; Sharp SY; Hobbs S; Workman P Cancer Res; 2008 Feb; 68(4):1188-97. PubMed ID: 18281495 [TBL] [Abstract][Full Text] [Related]
49. The Hsp90 inhibitor IPI-504 rapidly lowers EML4-ALK levels and induces tumor regression in ALK-driven NSCLC models. Normant E; Paez G; West KA; Lim AR; Slocum KL; Tunkey C; McDougall J; Wylie AA; Robison K; Caliri K; Palombella VJ; Fritz CC Oncogene; 2011 Jun; 30(22):2581-6. PubMed ID: 21258415 [TBL] [Abstract][Full Text] [Related]
50. The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells. Hirakawa H; Fujisawa H; Masaoka A; Noguchi M; Hirayama R; Takahashi M; Fujimori A; Okayasu R Cancer Med; 2015 Mar; 4(3):426-36. PubMed ID: 25582113 [TBL] [Abstract][Full Text] [Related]
51. Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents. Miyata Y Curr Pharm Des; 2005; 11(9):1131-8. PubMed ID: 15853661 [TBL] [Abstract][Full Text] [Related]
52. Blind cavefish and heat shock protein chaperones: a novel role for hsp90alpha in lens apoptosis. Hooven TA; Yamamoto Y; Jeffery WR Int J Dev Biol; 2004; 48(8-9):731-8. PubMed ID: 15558465 [TBL] [Abstract][Full Text] [Related]
53. Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis. Sanderson S; Valenti M; Gowan S; Patterson L; Ahmad Z; Workman P; Eccles SA Mol Cancer Ther; 2006 Mar; 5(3):522-32. PubMed ID: 16546966 [TBL] [Abstract][Full Text] [Related]
54. Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. Shimamura T; Lowell AM; Engelman JA; Shapiro GI Cancer Res; 2005 Jul; 65(14):6401-8. PubMed ID: 16024644 [TBL] [Abstract][Full Text] [Related]
55. Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation. Yun BG; Matts RL Exp Cell Res; 2005 Jul; 307(1):212-23. PubMed ID: 15922741 [TBL] [Abstract][Full Text] [Related]
56. BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90. Lundgren K; Zhang H; Brekken J; Huser N; Powell RE; Timple N; Busch DJ; Neely L; Sensintaffar JL; Yang YC; McKenzie A; Friedman J; Scannevin R; Kamal A; Hong K; Kasibhatla SR; Boehm MF; Burrows FJ Mol Cancer Ther; 2009 Apr; 8(4):921-9. PubMed ID: 19372565 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel. Sawai A; Chandarlapaty S; Greulich H; Gonen M; Ye Q; Arteaga CL; Sellers W; Rosen N; Solit DB Cancer Res; 2008 Jan; 68(2):589-96. PubMed ID: 18199556 [TBL] [Abstract][Full Text] [Related]
58. 17-DMAG-loaded nanofibrous scaffold for effective growth inhibition of lung cancer cells through targeting HSP90 gene expression. Mellatyar H; Talaei S; Pilehvar-Soltanahmadi Y; Dadashpour M; Barzegar A; Akbarzadeh A; Zarghami N Biomed Pharmacother; 2018 Sep; 105():1026-1032. PubMed ID: 30021337 [TBL] [Abstract][Full Text] [Related]
59. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells. Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590 [TBL] [Abstract][Full Text] [Related]
60. Key role of heat shock protein 90 in leptin-induced STAT3 activation and feeding regulation. Hosoi T; Kohda T; Matsuzaki S; Ishiguchi M; Kuwamura A; Akita T; Tanaka J; Ozawa K Br J Pharmacol; 2016 Aug; 173(15):2434-45. PubMed ID: 27205876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]